Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors.

Many neuropeptides are present in the peripheral nerves of human skin and are distributed from the intraepidermis to subcutaneous appendages, and those peptides are considered to be involved in the pathogenesis of various inflammatory dermatoses. In this investigation, we determined the effects of various neuropeptides on intracellular cyclic adenosine-5'-monophosphate (AMP) formation in cultured human keratinocytes. Among the many peptides tested, calcitonin gene-related peptide (CGRP), vasoactive intestinal polypeptide (VIP), peptide histidine-methionine (PHM), and growth hormone releasing factor (GRF) stimulated a rapid and marked formation of intracellular cyclic AMP in keratinocytes in a dose-dependent manner. The direct association of the receptors for CGRP and VIP with adenylyl cyclase in keratinocytes was confirmed by the findings that CGRP and VIP stimulated the enzyme activity in membrane preparations derived from cultured keratinocytes in the presence of guanosine triphosphate (GTP). On the other hand, neuropeptide Y (NPY) showed an inhibitory effect on forskolin-induced cyclic AMP accumulation in keratinocytes. This inhibitory effect of NPY was completely eliminated by glucocorticoid pretreatment of cultured keratinocytes. Furthermore, the presence of peptides that substantially increase intracellular cyclic AMP accumulation also stimulated DNA synthesis and proliferation in a human keratinocyte cell line in a dose-dependent manner. These results suggest that neuropeptides work directly as biologic modulators of keratinocytes through the cyclic AMP cascade.

[1]  E. Farber,et al.  Neuropeptides modulate leukotriene B4 mitogenicity toward cultured human keratinocytes. , 1993, The Journal of investigative dermatology.

[2]  Å. Sjöholm.  Intracellular signal transduction pathways that control pancreatic β‐cell proliferation , 1992, FEBS letters.

[3]  S. Nakanishi,et al.  Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. , 1992, The Journal of biological chemistry.

[4]  R. Shigemoto,et al.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide , 1992, Neuron.

[5]  A. Giannetti,et al.  Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. , 1992, The Journal of investigative dermatology.

[6]  S. Nakanishi,et al.  The primary structure and gene organization of human substance P and neuromedin K receptors. , 1992, European journal of biochemistry.

[7]  K. Tsuchida,et al.  Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. , 1992, The Journal of biological chemistry.

[8]  E. Goetzl,et al.  Cloning and expression of the human vasoactive intestinal peptide receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Shaw,et al.  Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. , 1991, The Journal of investigative dermatology.

[10]  S. Nakanishi,et al.  Selective inhibition of expression of the substance P receptor mRNA in pancreatic acinar AR42J cells by glucocorticoids. , 1990, The Journal of biological chemistry.

[11]  E. Farber,et al.  The Role of Cutaneous Sensory Nerves in the Maintenance of Psoriasis , 1990, International journal of dermatology.

[12]  A. Haegerstrand,et al.  Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Williams Tj,et al.  Neuropharmacology of peptides in skin. , 1988 .

[14]  Bernstein Je.  Capsaicin in dermatologic disease. , 1988 .

[15]  E. Weihe,et al.  Multiple peptides in cutaneous nerves: regulators under physiological conditions and a pathogenetic role in skin disease? , 1988, Seminars in dermatology.

[16]  M. Caron,et al.  Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. , 1988, The Journal of biological chemistry.

[17]  B. Lynn,et al.  Substance P content of the skin, neurogenic inflammation and numbers of C-fibres following capsaicin application to a cutaneous nerve in the rabbit , 1988, Neuroscience.

[18]  P. Holzer,et al.  Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides , 1988, Neuroscience.

[19]  R. Håkanson,et al.  Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responses. , 1987, European journal of pharmacology.

[20]  M. Rapaport,et al.  Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. , 1986, Journal of the American Academy of Dermatology.

[21]  K. Yoshikawa,et al.  Activation of cAMP-dependent protein kinase in epidermis by the compounds which increase epidermal cAMP. , 1981, The Journal of investigative dermatology.

[22]  K. Aso,et al.  Establishment of a cell line of human skin squamous cell carcinoma in vitro , 1981, The British journal of dermatology.

[23]  H. Green,et al.  Cyclic AMP in relation to proliferation of the Epidermal cell: a new view , 1978, Cell.

[24]  H. Green.  Terminal differentiation of cultured human epidermal cells , 1977, Cell.

[25]  H. Iizuka,et al.  Adenosine and adenine nucleotides stimulation of skin (epidermal) adenylate cyclase. , 1976, Biochimica et biophysica acta.

[26]  K. Halprin,et al.  Histamine (H2) receptor-adenylate cyclase system in pig skin (epidermis). , 1976, Biochimica et biophysica acta.

[27]  K. Yoshikawa,et al.  The effects of catecholamine and related compounds on the adenyl cyclase system in the epidermis * , 1975, The British journal of dermatology.

[28]  K. Yoshikawa,et al.  Prostaglandins and cyclic AMP in epidermis , 1975, The British journal of dermatology.

[29]  F. Marks,et al.  Diurnal fluctuation and -adrenergic elevation of cyclic AMP in mouse epidermis in vivo. , 1972, Nature: New biology.

[30]  J. Voorhees,et al.  Dibutyryl cyclic AMP inhibition of epidermal cell division. , 1972, Archives of dermatology.

[31]  Q. Zhou.  Molecular characterization of g-protein coupled receptors , 1992 .

[32]  T. McCall,et al.  Nitric oxide takes centre-stage with newly defined roles. , 1992, Trends in pharmacological sciences.

[33]  M. Caron,et al.  Molecular characterization of G-protein coupled receptors: isolation and cloning of a D1 dopamine receptor. , 1991, Journal of receptor research.

[34]  S. Watson,et al.  TiPS receptor nomenclature supplement. , 1990, Trends in pharmacological sciences.

[35]  D. Payan.  Neuropeptides and inflammation: the role of substance P. , 1989, Annual review of medicine.

[36]  W. Epstein,et al.  Dibutyryl cyclic AMP-induced differentiation of epidermal cells in tissue culture. , 1976, The Journal of investigative dermatology.

[37]  K. Elgjo.  Epidermal chalone and cyclic AMP: an in vivo study. , 1975, The Journal of investigative dermatology.